Are Doctors Overprescribing Antipsychotics to People with Autism?

PFAS exposure language delays in children
Elderly nice psychotherapist working with young autistic boy. Sitting in colorful office with toys
Last updated:

A new study is suggesting that the number of adolescents with autism or other intellectual disabilities who are being treated with antipsychotics has gone up in recent years.

Researchers at Hofstra Northwell School of Medicine in New York conducted a meta-analysis — a study of studies — that included 39 studies that included more than 350,000 young people with mental illnesses. More specifically, they examined the frequency and when antipsychotics were prescribed to youths with autism or intellectual disability.

About 1 in 6 adolescents diagnosed with autism has been prescribed antipsychotics, with the number increasing, the researchers reported in the Journal of the American Academy of Child & Adolescent Psychiatry. In addition, about 1 in 10 youths treated with an antipsychotic are diagnosed with autism or intellectual disability,

“Although the increased prescribing of antipsychotics in youth with autism spectrum disorders or intellectual disability cannot be judged as appropriate or inappropriate based on database studies, side effects of antipsychotics can be quite problematic, especially in children and adolescents,” lead author Christoph U. Correll, MD, said in a statement.

Second-generation antipsychotics are actually the only FDA-approved medications for the treatment of autism. However, they do not seem to impact the core symptoms of autism, such as social and communication difficulties, or the core symptoms of intellectual disability, such as problems with understanding and responding appropriately to information from the outside world.

The researchers conclude that doctors should consider using psychosocial interventions that are proven to work well for irritability and aggression, before prescribing antipsychotics to adolescents with autism or intellectual disability.

“Clinicians should perform very careful risk: benefit evaluation before and after starting youth with autism spectrum disorders or intellectual disability on an antipsychotic, always trying to maximize non-pharmacologic interventions as well as pharmacologic or non-pharmacologic treatments for comorbidities, including attention-deficit/hyperactivity disorder, anxiety disorders, obsessive-compulsive disorder, and sleep disorders,” Correll noted.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x